Envista Schedules First Quarter 2024 Earnings Call
Envista Schedules First Quarter 2024 Earnings Call
BREA, Calif., April 4, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its first quarter 2024 on Wednesday, May 1, 2024. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour.
加利福尼亚州布雷亚，2024年4月4日 /PRNewswire/ — Envista Holdings Corporation（纽约证券交易所代码：NVST）（“Envista”）将于2024年5月1日星期三公布其2024年第一季度的财务业绩。Envista将在当天的电话会议上讨论这些结果，电话会议从太平洋时间下午2点开始，持续约一小时。
The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, . A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. You can access the conference call by dialing 800-225-9448 within the U.S. or +1 203-518-9708 outside the U.S. a few minutes before 2:00 PM PT and referencing conference ID #4678913.
电话会议和随附的幻灯片演示将在Envista网站的 “投资者” 部分进行网络直播。网络直播的重播将在演示结束后不久播出，并将持续一年。在太平洋时间下午 2:00 前几分钟，在美国境内拨打 800-225-9448 或在美国境外拨打 +1 203-518-9708，并引用会议 ID #4678913 来参加电话会议。
Envista's earnings press release, the webcast slides, and other related presentation materials will be posted to the "Investors" section of Envista's website before the conference call and will remain available following the call.
Envista的财报新闻稿、网络直播幻灯片和其他相关演示材料将在电话会议之前发布到Envista网站的 “投资者” 部分，并将在电话会议结束后继续提供。
ABOUT ENVISTA HOLDINGS CORPORATION
关于 ENVISTA 控股公司
Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services. Its comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile. With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry. For more information, please visit .
Envista是一个由30多个值得信赖的牙科品牌组成的全球大家庭，包括Nobel Biocare、Ormco、DEXIS和Kerr，他们的共同目标是：与专业人士合作改善生活。Envista 通过行业领先的牙科耗材、解决方案、技术和服务，帮助其客户提供尽可能好的患者护理。其全面的产品组合，包括牙科植入物和治疗方案、正畸和数字成像技术，涵盖了牙医在诊断、治疗和预防牙科疾病以及改善人类微笑美感方面的广泛临床需求。凭借成熟的Envista业务系统（EBS）方法、经验丰富的领导团队以及基于持续改进、对创新的承诺和对客户的深刻关注的强大文化，Envista有能力满足全球牙科专业人员的端到端需求。Envista是全球最大的牙科产品公司之一，在牙科产品行业的一些最具吸引力的细分市场中占有重要的市场地位。欲了解更多信息，请访问。
FOR FURTHER INFORMATION
Stephen Keller
Principal Financial Officer
Envista Holdings Corporation
200 S. Kraemer Blvd., Building E
Brea, CA 92821
Telephone: (714) 817-7000
[email protected]
了解更多信息
斯蒂芬凯勒
首席财务官
Envista 控股公司
200 S. Kraemer Blvd.，E 楼
加利福尼亚州布雷亚 92821
电话：(714) 817-7000
[电子邮件保护]
SOURCE Envista Holdings Corporation
来源 Envista 控股公司